The evolving role of platelet glycoprotein IIb/IIIa inhibitors in the management of acute coronary syndromes.

Abstract

OBJECTIVE To briefly discuss the pathophysiology of acute coronary syndromes (ACS) and to present the clinical data currently available regarding the use of platelet glycoprotein (GP) IIb/IIIa inhibitors in the management of ACS. DATA SOURCES Literature on antithrombotic therapy in ACS was identified using a MEDLINE search (January 1988-September 1998… (More)

Topics

  • Presentations referencing similar topics